This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

HRA response to EMA consultation on the updated (ICH) E6 (R2) on good clinical practice

Last updated on 4 Feb 2016

The European Medicines Agency’s (EMA) recently consulted on the addendum to the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) E6 (R2) guideline on good clinical practice (GCP)

Our response can be found here.

Back to news & updates

Shape the future of the HRA website.